Profile
MOTS ABT BSX-PA BSX SYK MDT
Company Name Motus GI Holdings, Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $1.92K $233.33B $175.45B $153.32B $150.40B $113.11B
Employees 0.02K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Ravit Ram Robert B. Ford Michael F. Mahoney Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha
Ratings
MOTS ABT BSX-PA BSX SYK MDT
Quant Rating Score 1 4 3 3 3
Quant Rating Strong Sell Buy Neutral Neutral Neutral
Trading
MOTS ABT BSX-PA BSX SYK MDT
Last Close $0.0003 $134.11 $122.18 $103.63 $391.81 $88.28
High 52 $0.07 $140.22 $122.18 $107.41 $399.9 $94.5
Low 52 - $100.07 $122.18 $72.96 $315.94 $76.84
Price vs. 52 Week High -99.57 % -4.36 % 0 % -3.52 % -2.02 % -6.58 %
Price vs. 52 Week Low 0 % 34.02 % 0 % 42.04 % 24.01 % 14.89 %
Total Return
MOTS ABT BSX-PA BSX SYK MDT
1 Month Return 0 % 0.3 % 0 % 0.51 % 2.74 % 3.2 %
3 Month Return 200 % 1.88 % 0 % 5.21 % 6.37 % 0.44 %
6 Month Return 200 % 17.82 % 0 % 14.26 % 8.41 % 9.04 %
9 Month Return -99.14 % 19.5 % 0 % 23.63 % 11.43 % 0.58 %
YTD Return 50 % 18.57 % 0 % 16.02 % 8.82 % 10.52 %
1 Year Return -99.3 % 30.91 % 0 % 36.14 % 18.01 % 14 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
MOTS ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.7 % - - 0.83 % 3.18 %
Dividend Paid and Capex Coverage Ration (TTM) - 1.57 % 3.96 % 3.96 % 2.2 % 1.29 %
Dividend Per Share (TTM) - 2.28 % - - 3.28 % 2.81 %
Payout Ratio (TTM) - 28.92 % 1.13 % 1.13 % 43.2 % 76.97 %
Profitability
MOTS ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM -195.31 % 55.89 % 67.15 % 67.15 % 63.57 % 64.06 %
Return on Assets TTM -69.6 % 16.58 % 5.06 % 5.06 % 6.21 % 5.09 %
Return on Equity TTM -170.94 % 30.76 % 9.56 % 9.56 % 10.73 % 9.62 %
Return on Capital Employed TTM -119.72 % 10.5 % 8.77 % 8.77 % 9.61 % 7.56 %
Net Income Per EBT TTM 100 % 183.58 % 81.97 % 81.97 % 85.78 % 82.85 %
EBT Per Ebit TTM 109.34 % 102.35 % 80.59 % 80.59 % 91.04 % 94.51 %
EBIT Per Revenue TTM -3514.06 % 16.97 % 17.52 % 17.52 % 15.77 % 17.76 %
Cash Flow To Debt Ratio TTM -167.31 % 67.59 % 32.56 % 32.56 % 29.81 % 24.7 %
Receivables Turnover TTM 1.58 4.38 6.52 6.52 5.86 5.15
Payables Turnover TTM - 4.43 5.74 5.74 - 4.74
Inventory Turnover TTM 1.66 2.81 2.01 2.01 1.66 2.12
Fixed Asset Turnover TTM 12.17 % 387.34 % 517.94 % 517.94 % 656.62 % 490.52 %
Asset Turnover TTM 1.81 % 51.99 % 43.73 % 43.73 % 50.47 % 36.58 %
Operating Cash Flow Per Share TTM -0.47 5.12 2.58 2.58 11.23 5.49
Free Cash Flow Per Share TTM -0.47 3.81 1.94 1.94 9.37 4.04
Cash Per Share TTM 57.4 % 391.71 % 49.08 % 49.08 % 631.12 % 699.13 %
Operating Cash Flow Sales Ratio TTM -3186.72 % 21.14 % 21.72 % 21.72 % 18.47 % 21 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 74.38 % 75.37 % 75.37 % 83.42 % 73.61 %
Cash Flow Coverage Ratios TTM -167.31 % 67.59 % 32.56 % 32.56 % 29.81 % 24.7 %
Price To Free Cash Flows Ratio TTM - 35.05 53.36 53.36 42.05 21.81
Price To Operating Cash Flows Ratio TTM - 26.18 40.16 40.16 35.03 16.07
Price Cash Flow Ratio TTM - 26.18 40.16 40.16 35.03 16.07
Income Statement (TTM)
MOTS ABT BSX-PA BSX SYK MDT
Revenue $0B $41.95B $16.75B $16.75B $22.6B $33.54B
Gross Profit $-0B $23.24B $11.49B $11.49B $14.44B $21.97B
Gross Profit Ratio -78.37% 55.41% 68.61% 68.61% 63.91% 65.51%
EBITDA $-0.01B $10.83B $3.86B $3.86B $5.72B $5.96B
Net Income $-0.01B $13.4B $1.85B $1.85B $2.99B $4.66B
EPS Diluted -15.89 7.64 1.25 1.25 7.76 3.61
Balance Sheet (MRQ)
MOTS ABT BSX-PA BSX SYK MDT
Long Term Debt $0B $13.52B $9.37B $9.37B $12.19B $25.64B
Total Liabilities $0B $33.51B $17.39B $17.39B $22.34B $43.42B
Total Equity $0B $47.9B $22B $22B $20.63B $48.26B
Total Investments $0B $1.24B $0.56B $0.56B $0.84B $6.75B
Total Debt $0B $15.02B $11.15B $11.15B $13.6B $28.52B
Total Assets $0.01B $81.41B $39.4B $39.4B $42.97B $91.68B
Cash Flow Statement (TTM)
MOTS ABT BSX-PA BSX SYK MDT
Net Income $-0.01B $13.4B $1.85B $1.85B $2.99B $4.69B
Inventory $0B $-0.06B $-0.23B $-0.23B $0.05B $-0.29B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.59B
Operating Cash Flow $-0.01B $8.56B $3.44B $3.44B $4.24B $7.04B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 134.11
ADGM Adagio Medical Holdings, Inc. 1.53
AEMD Aethlon Medical, Inc. 1.24
AFIB Acutus Medical, Inc. 0.002
AHCO AdaptHealth Corp. 9.37
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 196.98
ALUR Allurion Technologies Inc. 2.56
AMIX Autonomix Medical, Inc. Common Stock 1.52
ANIK Anika Therapeutics, Inc. 11.25
AORT Artivion, Inc. 30.85
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 2.15
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 10.96
AVNS Avanos Medical, Inc. 12.38
AVR Anteris Technologies Global Corp. Common Stock 3.71
AXDX Accelerate Diagnostics, Inc. 0.034
AXGN AxoGen, Inc. 11.06
ETFs With Exposure to MOTS
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 135.77
VXF Vanguard Extended Market Index Fund 0 195.67
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 148.44
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 148.45
VEMPX Vanguard Extended Market Index InstlPlus 0 366.31
Unlock